The Breast

  • Kathryn M. Andolsek
  • Joyce Copeland


The routine health assessment of any patient should include inquiries about symptoms related to the breast, previous breast surgery, pertinent family history (age of any first degree female relatives—mother or sisters—with breast cancer and the age at which their cancer or cancers developed in relation to menopause), pain, mass, or discharge (Table 108.1).


Breast Cancer Breast Cancer Risk African American Woman Family Physician American Cancer Society 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Martin LR. Early detection of breast cancer (home study audio No. 154). AAFP Home Study Self-Assessment. Kansas City, MO: American Academy of Family Physicians, March 1992.Google Scholar
  2. 2.
    O’Malley MS, Fletcher SW. Screening for breast cancer with breast self-examination. JAMA 1987;257:2197–203.Google Scholar
  3. 3.
    Hill D, White V, Jolley D, Mapperson F. Self examination of the breast: is it beneficial? Meta-analysis of studies investigating breast self examination and extent of disease in patients with breast cancer. BMJ 1988;297:271–5.PubMedCrossRefGoogle Scholar
  4. 4.
    Frank JW, Mai V. Breast self examination in young women: more harm than good? Lancet 1985;2:654–7.PubMedCrossRefGoogle Scholar
  5. 5.
    Coleman EA. Practice and effectiveness of breast self examination: a selective review of the literature. J Cancer Educ 1991; 6(2):83–92.PubMedCrossRefGoogle Scholar
  6. 6.
    Martin LR. Early detection of breast cancer (home study audio No. 154). American Academy of Family Physicians Home Study Self Assessment. Kansas City, MO: AAFP, March 1992.Google Scholar
  7. 7.
    Seidman H, Gelb SK, Silberberg E, Laverda N, Lubera JA. Survival experience in the breast cancer detection demonstration project. CA Cancer J Clin 1987;37:258–90.PubMedCrossRefGoogle Scholar
  8. 8.
    Shapiro S, Straz P, Venet W, Venet L, Roeser R. Ten to fourteen year effect of screening on breast cancer mortality. J Natl Cancer Inst 1982;69:349–55.PubMedGoogle Scholar
  9. 9.
    Tabar L, Fagerberg CJ, Gad A, et al. Reduction in mortality from breast cancer after mass screening with mammography: randomized trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1985; 1:829–32.PubMedCrossRefGoogle Scholar
  10. 10.
    Working guidelines for early detection: rationale and supporting evidence to decrease mortality. Bethesda: National Center Institute, 1987.Google Scholar
  11. 11.
    Summary of current guidelines for the cancer-related checkup: recommendations. New York: American Cancer Society, 1988.Google Scholar
  12. 12.
    Policy statement: guidelines for mammography. Reston, VA: American College of Radiology, 1982.Google Scholar
  13. 13.
    American College of Physicians Clinical Efficacy Assessment Project. The use of diagnostic tests for screening and evaluating breast lesions. Philadelphia: American College of Physicians, 1984.Google Scholar
  14. 14.
    Standards for obstetric-gynecologic services. 6th ed. Washington, DC: American College of Obstetricians and Gynecologists, 1985.Google Scholar
  15. 15.
    US Preventive Services Task Force Guide to Clinical Preventive Services. An assessment of the effectiveness of 169 intervention: US Preventive Services Task Force. Baltimore: Williams & Wilkins, 1989.Google Scholar
  16. 16.
    Recommendations for breast cancer screening. JAMA 1987;257: 2196–203.Google Scholar
  17. 17.
    Healthy people 2000: nation health promotion and disease prevention objectives. Public Health Service Publ. No. 91–50213. Washington, DC: Department of Health and Human Services, 1991.Google Scholar
  18. 18.
    Eddy DM, Hasselblad V, McGivney W, Hendee W The value of mammography screening in women under age 50 years. JAMA 1988;259:1512.PubMedCrossRefGoogle Scholar
  19. 19.
    Council on Scientific Affairs. Mammographie screening in asymptomatic women aged 40 years and older. JAMA 1989;261: 2535–42.CrossRefGoogle Scholar
  20. 20.
    Seidman H, Gelb SK, Silverberg E, LaVeroa N, Lubera J. Survival experience in the Breast Cancer Detection Demonstration Project. CA Cancer J Clin 1987;37:258.PubMedCrossRefGoogle Scholar
  21. 21.
    Fox SA, Murata PJ, Stein JA. The impact of physician compliance on screening mammography for older women. Arch Intern Med 1991;151:50–6.PubMedCrossRefGoogle Scholar
  22. 22.
    Rimer BK, Keintz MK, Kessler HB, Engstrom PF, Rosan JR. Why women resist screening mammography: patient related barriers. Radiology 1989;172:243–6.PubMedGoogle Scholar
  23. 23.
    Costanza ME, Stoddard AM, Zapka JG, Gaw VP, Barth R. Physician compliance with mammography guidelines. J Am Board Fam Pract 1992;5:143–52.PubMedGoogle Scholar
  24. 24.
    Zapka JG, Stoddard A, Maul L, Costanza ME. Interval adherence to mammography screening guidelines. Med Care 1991;29:697–707.PubMedCrossRefGoogle Scholar
  25. 25.
    Use of mammography in the United States. MMWR 1990;39: 621, 627–30.Google Scholar
  26. 26.
    Warner SL, Worden JK, Solomon LJ, Wadland WC. Physician interest in breast cancer screening education: a survey of Vermont family physicians. J Fam Pract 1989;29:281–5.PubMedGoogle Scholar
  27. 27.
    Kopans DB, Meyer JE, Sadowsky N. Breast imaging. N Engl J Med 1984;310:960–7.PubMedCrossRefGoogle Scholar
  28. 28.
    Gohagen JK, Darby WP, Spitznagel EL, Monsees BS, Tome AE. Radiogenic breast cancer effects of mammographic screening. J Natl Cancer Inst 1986;77:71.Google Scholar
  29. 29.
    Feig SA, Ehrlich SM. Estimation of radiation risk from screening mammography: recent trends and comparison with expected benefits. Radiology 1990;174:638–47.PubMedGoogle Scholar
  30. 30.
    Breast cancer study. Lawrenceville, NJ: Physicians Insurers Association of America, 1990.Google Scholar
  31. 31.
    Hutter RVP, editor. Goodbye to fibrocystic disease. N Engl J Med 1985;312:179.Google Scholar
  32. 32.
    Cancer facts and figures, 1989. Atlanta: American Cancer Society, 1991:10.Google Scholar
  33. 33.
    Sattin RW, Rubin GL, Webster LA, et al. Family history and the risk of breast cancer. JAMA 1985;253:1908.PubMedCrossRefGoogle Scholar
  34. 34.
    Martin LR. Early detection of breast cancer (home study audio no. 154). AAFP Home Study Self Assessment. Kansas City, MO: American Academy of Family Physicians, March 1992.Google Scholar
  35. 35.
    Schatzkin A, Jones Y, Hoover RN, et al. Alcohol consumption and breast cancer in the epidemiologic follow-up study of the first national health and nutrition examination survey. N Engl J Med 1987;316:1169–74.PubMedCrossRefGoogle Scholar
  36. 36.
    Longnecker MP, Berlin JA, Orza MJ, et al. A meta-analysis of alcohol consumption in relation to risk of breast cancer. JAMA 1988;260:652–6.PubMedCrossRefGoogle Scholar
  37. 37.
    Schatzkin A, Carter CL, Green SB, et al. Is alcohol consumption related to breast cancer? Results from the Framingham heart study. J Natl Cancer Inst 1989;81:31–5.PubMedCrossRefGoogle Scholar
  38. 38.
    Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985;312:146–51.PubMedCrossRefGoogle Scholar
  39. 39.
    Greenberg ER, Barnes AB, Resseguie L, et al. Breast cancer in mothers given diethylstilbestrol in pregnancy. N Engl J Med 1984;311:1393–9.PubMedCrossRefGoogle Scholar
  40. 40.
    Cancer and steroid hormone study of the Centers for Disease Control and the National Institute of Child Health and Human Development: oral contraceptive and the risk of breast cancer. N Engl J Med 1986;315:405–6.Google Scholar
  41. 41.
    Schlesselman JJ, Stadel BV, Murray P, Lai S. Breast cancer in relation to early use of oral contraceptives: no evidence of a latent effect. JAMA 1988;259:1828–33.PubMedCrossRefGoogle Scholar
  42. 42.
    UK National Case Control Study Group. Oral contraceptive use and breast cancer risk in young women. Lancet 1989;1:973–82.Google Scholar
  43. 43.
    Olsson H, Moller TR, Ranstam J. Early oral contraceptive use and breast cancer among premenopausal women: final report from a study in southern Sweden. J Natl Cancer Inst 1989;81: 1000–4.PubMedCrossRefGoogle Scholar
  44. 44.
    Paul C, Skegg DCG, Spears GFS, Kalder JM. Oral contraceptives and breast cancer: a national study. BMJ 1986;293:723–9.PubMedCrossRefGoogle Scholar
  45. 45.
    Schesselman JJ. Part I. Current concern in oral contraception: oral contraception and breast cancer. Am J Obstet Gynecol 1990;163:1379–87.CrossRefGoogle Scholar
  46. 46.
    Bergkvist L, Adami H-O, Persson I, et al. The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med 1989;321:293–7.PubMedCrossRefGoogle Scholar
  47. 47.
    Dupont WD, Page DL. Menopausal estrogen replacement therapy and breast cancer. Arch Intern Med 1991;151:67–72.PubMedCrossRefGoogle Scholar
  48. 48.
    Breast cancer and estrogen replacement [letter]. N Engl J Med 1990;322:201.Google Scholar
  49. 49.
    Byers T, Graham S, Rzepka T, Marshall J. Lactation and breast cancer: evidence for a negative association in premenopausal women. Am J Epidemiol 1985;121:664–74.PubMedCrossRefGoogle Scholar
  50. 50.
    Willett WC, Stampfer MJ, Colditz GA, Rosner BA, Hennekens CH, Speizer PE. Dietary fat and the risk of breast cancer. N Engl J Med 1987;316:22–8.PubMedCrossRefGoogle Scholar
  51. 51.
    Sellers TA, Kushi LH, Potter JD, et al. Effect of family history, body-fat distribution, and reproductive factors on the risk of postmenopausal breast cancer. N Engl J Med 1992;326:1323–9.PubMedCrossRefGoogle Scholar
  52. 52.
    Silverstein MJ, Gierson ED, Gamagami P, Handel N, Waisman JR. Breast cancer diagnosis and prognosis in women augmented with silicone gel-filled implants. Cancer 1990;66:97.PubMedCrossRefGoogle Scholar
  53. 53.
    Baquet CR, Ringern K, Pollack ES. Family practice in the inner city. In: Cancer among blacks and other minorities: statistical profiles. DHHS Publ. No. NIH 86–2785. Bethesda: National Cancer Institute, 1986.Google Scholar
  54. 54.
    Bain RP, Greenbery RS, Whitaker JP. Racial differences in survival of women with breast cancer. J Chronic Dis 1986;39:631–42.PubMedCrossRefGoogle Scholar
  55. 55.
    Chu J, Diehr P, Feigl P, et al. The effect of age on the care of women with breast cancer in community hospitals. J Gerontol 1987;42:185–90.PubMedCrossRefGoogle Scholar
  56. 56.
    Greenfield S, Blanco M, Elashoff RM, Ganz PA. Patterns of care related to age of breast cancer patients. JAMA 1987;257:2766–70.PubMedCrossRefGoogle Scholar
  57. 57.
    Stillman RA, Guadagnoli E, Weitberg AB, Mor V. Age as a predictor of diagnostic and initial treatment intensity in newly diagnosed breast cancer patients. J Gerontol 1989;44:M46-M50.CrossRefGoogle Scholar
  58. 58.
    Donegan WL. Evaluation of a palpable breast mass. N Engl J Med 1992;327:937–42.PubMedCrossRefGoogle Scholar
  59. 59.
    Connolly DP. Fine needle aspiration of the breast. Fam Pract Recertif 1992;14:32–7.Google Scholar
  60. 60.
    Stockdale FE. Breast cancer. Sect. 12, Ch. VII. New York: Scientific American Medicine, 2 April 1991.Google Scholar
  61. 61.
    National Institutes of Health Consensus Development Conference statement: treatment of early breast cancer. JAMA 1991; 265:391–5.Google Scholar
  62. 62.
    Connolly DP. Trends in surgical techniques and impact on prognosis. Fam Pract Recertif 1992;14:66–90.Google Scholar
  63. 63.
    Bonadonna G, Veronesi U, Brambilla C. Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. J Natl Cancer Inst 1990;82:1539–45.PubMedCrossRefGoogle Scholar
  64. 64.
    Farrow CD, Hunt WC, Samet JM. Geographic variation in the treatment of localized breast cancer. N Engl J Med 1992,326: 1097–1101.PubMedCrossRefGoogle Scholar
  65. 65.
    Nattinger AB, Gottlieb MS, Veum J, Yahnke D, Goodwin JS. Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med 1992;326:1102–7.PubMedCrossRefGoogle Scholar
  66. 66.
    Lazovich D, White E, Thomas DC, Moe RE. Underutilization of breast conserving surgery and radiation therapy among women with stage I or II breast cancer. JAMA 1991;266:3433–8.PubMedCrossRefGoogle Scholar
  67. 67.
    Wolberg WH. Surgical options in 424 patients with primary breast cancer without systemic metastases. Arch Surg 1991; 126:817–20.PubMedCrossRefGoogle Scholar
  68. 68.
    Ganz PA. Treatment options for breast cancer beyond survival. N Engl J Med 1992;326:1147–9.PubMedCrossRefGoogle Scholar
  69. 69.
    Fisher B, Brown A, Wolmark N, et al. Prolonged tamoxifen therapy for primary breast cancer. Ann Intern Med 1987;106: 649–57.PubMedCrossRefGoogle Scholar
  70. 70.
    Fisher B, Redmond C, Dimitrov NV, et al. A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node negative breast cancer who have ER-positive tumors. N Engl J Med 1989;320:473–9.PubMedCrossRefGoogle Scholar
  71. 71.
    Fisher B, Constantine J, Redmond C. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have ER-positive tumors. N Engl J Med 1989;320:479–84.PubMedCrossRefGoogle Scholar
  72. 72.
    Mansour EG, Gray R, Shatila AH, et al. Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer: an inter-group study. N Engl J Med 1989;320:485–90.PubMedCrossRefGoogle Scholar
  73. 73.
    Harris JR, Henderson IC. Natural history and staging of breast cancer. In: Harris JR, Hellman S, Henderson IC, Kinne DW, editors. Breast disease. Philadelphia: Lippincott, 1987:233.Google Scholar
  74. 74.
    Fisher B, Redmon D, Fisher ER, et al. Ten year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985;312: 674–87.PubMedCrossRefGoogle Scholar
  75. 75.
    Tobin M. Breast cancer: the family physician’s role (home study audio no. 154). AAFP Home Study Self Assessment. Kansas City, MO: American Academy of Family Physicians, March 1992.Google Scholar
  76. 76.
    Bostwick J III. Breast reconstruction following mastectomy. CA Cancer J Clin 1989,39:40.PubMedCrossRefGoogle Scholar
  77. 77.
    Recht A, Danoff BS, Solin LJ, et al. Intraductal carcinoma of the breast: results of treatment with excisional biopsy and irradiation. J Clin Oncol 1985;3:1339.PubMedGoogle Scholar
  78. 78.
    Schnitt SJ, Connolly JL, Recht A, Silver B, Harnes JR. Influence of infiltrating lobular histology on local tumor control in breast cancer patients treated with conservative surgery and radiotherapy. Cancer 1989;64:448–51.PubMedCrossRefGoogle Scholar
  79. 79.
    Chittoor SR, Swain SM. Adjuvant therapy in early breast cancer. Am Fam Physician 1991;44:453–62.PubMedGoogle Scholar
  80. 80.
    McGuire WL, Clark GM. Prognostic factors and treatment decisions in axillary node negative breast cancer. N Engl J Med 1992;326:1756–61.PubMedCrossRefGoogle Scholar
  81. 81.
    Harris JR, Lippman ME, Veronesi U, Willett U. Breast cancer (first of three parts). N Engl J Med 1992;327:319–28.PubMedCrossRefGoogle Scholar
  82. 82.
    Harris JR, Lippman ME, Veronesi U, Willett U. Breast cancer (second of three parts). N Engl J Med 1992;327:473–80.PubMedCrossRefGoogle Scholar
  83. 83.
    Harris JR, Lippman ME, Veronesi U, Willett U. Breast cancer (third of three parts). N Engl J Med 1992;327:573–80.Google Scholar
  84. 84.
    Antman K, Gale RR Advanced breast cancer: high dose chemotherapy and bone marrow autotransplants. Ann Intern Med 1988;108:570–4.PubMedCrossRefGoogle Scholar
  85. 85.
    Curtis RE. Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N Engl J Med 1992;326:1745–51.PubMedCrossRefGoogle Scholar
  86. 86.
    Kiebert GM, deHaes JCJM, van de Velde CJH. The impact of breast conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients: a review. J Clin Oncol 1991;9:1059–70.PubMedGoogle Scholar
  87. 87.
    Fallowfield LJ, Hall A, Maguire GP, Baum M. Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial. BMJ 1990;301:575–80.PubMedCrossRefGoogle Scholar
  88. 88.
    Gonzalez S, Steinglass P, Reiss D. Putting illness in its place: discussion groups for families with chronic medical illness. Fam Process 1989;28:69–75.PubMedCrossRefGoogle Scholar
  89. 89.
    Holmberg L, Omne-Ponten M, Burns I, Adami HO, Bergstrom R. Psychosocial adjustment after mastectomy and breast-conserving treatment. Cancer 1989;64:969–74.PubMedCrossRefGoogle Scholar
  90. 90.
    Redd WH, Silberfarb PM, Andersen BL, et al. Physiologic and psychobehavioral research in oncology. Cancer 1991;67 Suppl 3:813.CrossRefGoogle Scholar
  91. 91.
    Schover LR. The impact of breast cancer on sexuality, body image and intimate relationships. CA Cancer J Clin 1991;41:112–20.PubMedCrossRefGoogle Scholar
  92. 92.
    Spiegel D, Kraemer MC, Bloom JR, Gottheil E. Effects of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 1989;2:888–96.PubMedCrossRefGoogle Scholar
  93. 93.
    Vinokur AD, Threatt BA, Caplan RD, Zimmerman BL. Physical and psychosocial functioning and adjustment to breast cancer: longer-term follow-up of a screening population. Cancer 1989;6: 394–405.CrossRefGoogle Scholar
  94. 94.
    Reiss M. Psychosocial impact of breast cancer: implications for patient management. Fam Pract Recertif 1992;6:31–55.Google Scholar
  95. 95.
    Connolly DP. Fine needle aspiration of the breast. Fam Pract Recertif 1992;14(4):32–37.Google Scholar
  96. 96.
    Federman DD. The pituitary. In Chapter 3 section of Endocrinology 3:V:8. New York: Scientific American Medicine, 1985.Google Scholar
  97. 97.
    Kramish Campbell M, Waller L, Andolsek K, Huff P, Bucci K. Infant feeding and nutrition in obstetric care. In: Andolsek K, editor. Standards of prenatal, intrapartrient postpartum management. Philadelphia: Lea & Febiger, 1990.Google Scholar
  98. 98.
    Field DA, Miller S. Cosmetic breast surgery. Am Fam Physician 1992;45:711–9.PubMedGoogle Scholar
  99. 99.
    McGrath MH, Burkhardt BR. The safety and efficacy of breast implants for augmentation mammoplasty. Plast Reconstr Surg 1984;74:550–60.PubMedCrossRefGoogle Scholar
  100. 100.
    Field DA, Miller S. Cosmetic breast surgery. Am Fam Physician 1992;45:711–9.PubMedGoogle Scholar
  101. 101.
    Berkel H, Birdsell DC, Jenkins H. Breast augmentation: a risk factor for breast cancer? N Engl J Med 1992;326:1649–53.PubMedCrossRefGoogle Scholar
  102. 102.
    Silicone gel implants. FDA medical bulletin 1992;22(1):3.Google Scholar
  103. 103.
    Silverstein MJ, Handel N, Waisman JR, et al. Breast cancer diagnosis and prognosis in women augmented with silicone gel-filled implants. Cancer 1990;66:97–104.PubMedCrossRefGoogle Scholar
  104. 104.
    Silverstein MJ, Handel N, Waisman JR, et al. The effect of silicone gel-filled implants on mammography. Cancer 1991;68: 1159–63.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Kathryn M. Andolsek
  • Joyce Copeland

There are no affiliations available

Personalised recommendations